Endothelin-converting enzyme-1 in Alzheimer's disease and vascular dementia

Neuropathology and Applied Neurobiology

Volumn 36, Issue 6, 2010, Pages 487-497

  Palmer, J C ^a   Kehoe, P G ^a   Love, S ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

amyloid; Alzheimer's disease; cerebral blood flow; cerebrovascular dysfunction; endothelin; endothelin converting enzyme

Indexed keywords

ENDOTHELIN CONVERTING ENZYME; MESSENGER RNA; VON WILLEBRAND FACTOR;

AGED; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MULTIINFARCT DEMENTIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TEMPORAL CORTEX; WESTERN BLOTTING;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; ASPARTIC ACID ENDOPEPTIDASES; BLOTTING, WESTERN; DEMENTIA, VASCULAR; ENDOTHELIAL CELLS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; METALLOENDOPEPTIDASES; MIDDLE AGED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR MARKERS, BIOLOGICAL;

EID: 77956497978     PISSN: 03051846     EISSN: 13652990     Source Type: Journal    
DOI: 10.1111/j.1365-2990.2010.01084.x     Document Type: Article

References (59)

1. Tanzi RE, Bertram L. Twenty years of the Alzheimer's disease amyloid hypothesis: a genetic perspective. Cell 2005 120 : 545 555
2. Li R, Lindholm K, Yang LB, Yue X, Citron M, Yao RQ, Beach T, Sue L, Sabbagh M, Cai HB, Wong P, Price D, Shen Y. Amyloid β peptide load is correlated with increased β-secretase activity in sporadic Alzheimer's disease patients. Proc Natl Acad Sci U S A 2004 101 : 3632 3637
3. Yang LB, Lindholm K, Yan RQ, Citron M, Xia WM, Yang XL, Beach T, Sue L, Wong P, Price D, Li R, Shen Y. Elevated β-secretase expression and enzymatic activity detected in sporadic Alzheimer disease. Nat Med 2003 9 : 3 4
4. Tyler SJ, Dawbarn D, Wilcock GK, Allen SJ. α- and β-secretase: profound changes in Alzheimer's disease. Biochem Biophys Res Commun 2002 299 : 373 376
5. Zhao J, Fu YF, Yasvoina M, Shao PZ, Hitt B, O'Connor T, Logan S, Maus E, Citron M, Berry R, Binder L, Vassar R. B-site amyloid precursor protein cleaving enzyme 1 levels become elevated in neurons around amyloid plaques: implications for Alzheimer's disease pathogenesis. J Neurosci 2007 27 : 3639 3649
6. Preston SD, Steart PV, Wilkinson A, Nicoll JAR, Weller RO. Capillary and arterial cerebral amyloid angiopathy in Alzheimer's disease: defining the perivascular route for the elimination of amyloid β from the human brain. Neuropathol Appl Neurobiol 2003 29 : 106 117
7. Weller RO, Massey A, Newman TA, Hutchings M, Kuo YM, Roher AE. Cerebral amyloid angiopathy - Amyloid-β accumulates in putative interstitial fluid drainage pathways in Alzheimer's disease. Am J Pathol 1998 153 : 725 733
8. Lam FC, Liu RH, Lu PH, Shapiro AB, Renoir JM, Sharom FJ, Reiner PB. β-Amyloid efflux mediated by p-glycoprotein. J Neurochem 2001 76 : 1121 1128
9. 1-40 peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier. J Clin Invest 2000 106 : 1489 1499
10. Eckman EA, Eckman CB. Aβ-degrading enzymes: modulators of Alzheimer's disease pathogenesis and targets for therapeutic intervention. Biochem Soc Trans 2005 33 : 1101 1105
11. Jacobsen JS, Comery TA, Martone RL, Elokdah H, Crandall DL, Oganesian A, Aschmies S, Kirksey Y, Gonzales C, Xu J, Zhou H, Atchison K, Wagner E, Zaleska MM, Das I, Arias RL, Bard J, Riddell D, Gardell SJ, Abou-Gharbia M, Robichaud A, Magolda R, Vlasuk GP, Bjornsson T, Reinhart PH, Pangalos MN. Enhanced clearance of Aβ in brain by sustaining the plasmin proteolysis cascade. Proc Natl Acad Sci U S A 2008 105 : 8754 8759
12. Jiang Q, Lee CYD, Mandrekar S, Wilkinson B, Cramer P, Zelcer N, Mann K, Lamb B, Willson TM, Collins JL, Richardson JC, Smith JD, Comery TA, Riddell D, Holtzman DM, Tontonoz P, Landreth GE. ApoE promotes the proteolytic degradation of Aβ. Neuron 2008 58 : 681 693
13. Hoang MV, Turner AJ. Novel activity of endothelin-converting enzyme: hydrolysis of bradykinin. Biochem J 1997 327 : 23 6
14. Johnson GD, Stevenson T, Ahn KH. Hydrolysis of peptide hormones by endothelin-converting enzyme-1 - a comparison with neprilysin. J Biol Chem 1999 274 : 4053 4058
15. Eckman EA, Reed DK, Eckman CB. Degradation of the Alzheimer's amyloid-β peptide by endothelin-converting enzyme. J Biol Chem 2001 276 : 24540 24548
16. Valdenaire O, Rohrbacher E, Mattei MG. Organization of the gene encoding the human endothelin-converting enzyme (ECE-1). J Biol Chem 1995 270 : 29794 29798
17. Sluck JM, Lin RCS, Katolik LI, Jeng AY, Lehmann JC. Endothelin converting enzyme-1-, endothelin-1-, and endothelin-3-like immunoreactivity in the rat brain. Neuroscience 1999 91 : 1483 1497
18. Naidoo V, Naidoo S, Mahabeer R, Raidoo DM. Cellular distribution of the endothelin system in the human brain. J Chem Neuroanat 2004 27 : 87 98
19. Funalot B, Ouimet T, Claperon A, Fallet C, Delacourte A, Epelbaum J, Subkowski T, Leonard N, Codron V, David JP, Amouyel P, Schwartz JC, Helbecque N. Endothelin-converting enzyme-1 is expressed in human cerebral cortex and protects against Alzheimer's disease. Mol Psychiatry 2004 9 : 1122 1128 (Pubitemid 40065457)
20. Ahn K, Pan S, Beningo K, Hupe D. A permanent human cell line (EA.hy926) preserves the characteristics of endothelin converting enzyme from primary human umbilical vein endothelial cells. Life Sci 1995 56 : 2331 2341
21. Xu D, Emoto N, Giaid A, Slaughter C, Kaw S, Dewit D, Yanagisawa M. ECE-1 - a membrane-bound metalloprotease that catalyzes the proteolytic activation of big endothelin-1. Cell 1994 78 : 473 485
22. Eckman EA, Watson M, Marlow L, Sambamurti K, Eckman CB. Alzheimer's disease β-amyloid peptide is increased in mice deficient in endothelin-converting enzyme. J Biol Chem 2003 278 : 2081 2084
23. Palmer JC, Baig S, Kehoe PG, Love S. Endothelin-converting enzyme-2 is increased in Alzheimer's disease and up-regulated by Aβ. Am J Pathol 2009 175 : 262 270
24. Braak H, Braak E. Neuropathological staging of Alzheimer-related changes. Acta Neuropathol (Berl) 1991 82 : 239 259
25. -δδCT Method. Methods 2001 25 : 402 408
26. Klipper E, Levy N, Gilboa T, Muller L, Meidan R. Identification of a novel alternatively spliced variant endothelin converting enzyme-1 lacking a transmembrane domain. Exp Biol Med 2006 231 : 723 728
27. Meidan R, Klipper E, Gilboa T, Muller L, Levy N. Endothelin-converting enzyme-1, abundance of isoforms a-d and identification of a novel alternatively spliced variant lacking a transmembrane domain. J Biol Chem 2005 280 : 40867 40874
28. Fuller SJ, Storey E, Li QX, Smith AI, Beyreuther K, Masters CL. Intracellular production of βA4 amyloid of Alzheimer's disease: modulation by phosphoramidon and lack of coupling to the secretion of the amyloid precursor protein. Biochemistry (Mosc) 1995 34 : 8091 8098
29. Yanagisawa H, Hammer RE, Richardson JA, Emoto N, Williams SC, Takeda S, Clouthier DE, Yanagisawa M. Disruption of ECE-1 and ECE-2 reveals a role for endothelin-converting enzyme-2 in murine cardiac development. J Clin Invest 2000 105 : 1373 1382
30. Ehrenreich H, Schilling L. New developments in the understanding of cerebral vasoregulation and vasospasm - the endothelin nitric-oxide network. Cleve Clin J Med 1995 62 : 105 116
31. Haynes WG, Ferro CJ, O'Kane KP, Somerville D, Lomax CC, Webb DJ. Systemic endothelin receptor blockade decreases peripheral vascular resistance and blood pressure in humans. Circulation 1996 93 : 1860 1870
32. Haynes WG, Webb DJ. Contribution of endogenous generation of endothelin-1 to basal vascular tone See comment Lancet 1994 344 : 852 854
33. Shah R. Endothelins in health and disease. Eur J Intern Med 2007 18 : 272 282
34. Wright CE, Fozard JR. Regional vasodilation is a prominent feature of the haemodynamic response to endothelin in anaesthetized, spontaneously hypertensive rats. Eur J Pharmacol 1988 155 : 201 203
35. Kalaria RN. Cerebral vessels in ageing and Alzheimer's disease. Pharmacol Ther 1996 72 : 193 214
36. Kalaria RN. Linking cerebrovascular defense mechanisms in brain ageing and Alzheimer's disease. Neurobiol Aging 2009 30 : 1512 1514
37. Jagust WJ. Neuroimaging in dementia. Neurol Clin 2000 18 : 885 901
38. Dekosky ST, Shih WJ, Schmitt FA, Coupal J, Kirkpatrick C. Assessing utility of single photon emission computed tomography spect scan in Alzheimer disease correlation with cognitive severity. Alzheimer Dis Assoc Disord 1990 4 : 14 23
39. Imran MB, Kawashima R, Awata S, Sato K, Kinomura S, Ono S, Sato M, Fukuda H. Tc-99m HMPAO SPECT in the evaluation of Alzheimer's disease: correlation between neuropsychiatric evaluation and CBF images. J Neurol Neurosurg Psychiatry 1999 66 : 228 232
40. Shiraishi H, Chang CC, Kanno H, Yamamoto I. The relationship between cerebral blood flow and cognitive function in patients with brain insult of various etiology. J Clin Neurosci 2004 11 : 138 141
41. Buee L, Hof PR, Bouras C, Delacourte A, Perl DP, Morrison JH, Fillit HM. Pathological alterations of the cerebral microvasculature in Alzheimers-disease and related dementing disorders. Acta Neuropathol (Berl) 1994 87 : 469 480
42. Iadecola C, Zhang FY, Niwa K, Eckman C, Turner SK, Fischer E, Younkin S, Borchelt DR, Hsiao KK, Carlson GA. SOD1 rescues cerebral endothelial dysfunction in mice overexpressing amyloid precursor protein. Nat Neurosci 1999 2 : 157 161
43. Niwa K, Kazama K, Younkin L, Younkin SG, Carlson GA, Iadecola C. Cerebrovascular autoregulation is profoundly impaired in mice overexpressing amyloid precursor protein. Am J Physiol Heart Circ Physiol 2002 283 : H315 23
44. Niwa K, Kazama K, Younkin SG, Carlson GA, Iadecola C. Alterations in cerebral blood flow and glucose utilization in mice overexpressing the amyloid precursor protein. Neurobiol Dis 2002 9 : 61 8
45. Arendash GW, Su GC, Crawford FC, Bjugstad KB, Mullan M. Intravascular β-amyloid infusion increases blood pressure: implications for a vasoactive role of β-amyloid in the pathogenesis of Alzheimer's disease. Neurosci Lett 1999 268 : 17 20
46. Suo ZM, Humphrey J, Kundtz A, Sethi F, Placzek A, Crawford F, Mullan M. Soluble Alzheimers β-amyloid constricts the cerebral vasculature in vivo. Neurosci Lett 1998 257 : 77 80
47. 1-40 reproduces cerebrovascular alterations resulting from amyloid precursor protein overexpression in mice. J Cereb Blood Flow Metab 2000 20 : 1659 1668
48. Price JM, Chi XD, Hellermann G, Sutton ET. Physiological levels of β-amyloid induce cerebral vessel dysfunction and reduce endothelial nitric oxide production. Neurol Res 2001 23 : 506 512
49. Price JM, Sutton ET, Hellermann A, Thomas T. β-Amyloid induces cerebrovascular endothelial dysfunction in the rat brain. Neurol Res 1997 19 : 534 538
50. Thomas T, McLendon C, Sutton ET, Thomas G. Cerebrovascular endothelial dysfunction mediated by β-amyloid. Neuroreport 1997 8 : 1387 1391 (Pubitemid 27242542)
51. Thomas T, Thomas G, McLendon C, Sutton T, Mullan M. β-Amyloid- mediated vasoactivity and vascular endothelial damage. Nature 1996 380 : 168 171
52. Gentile MT, Vecchione C, Maffei A, Aretini A, Marino G, Poulet R, Capobianco L, Selvetella G, Lembo G. Mechanisms of soluble β-amyloid impairment of endothelial function. J Biol Chem 2004 279 : 48135 48142
53. Crawford F, Suo ZM, Fang CH, Mullan M. Characteristics of the in vitro vasoactivity of β-amyloid peptides. Exp Neurol 1998 150 : 159 168
54. Chisari M, Merlo S, Sortino MA, Salomone S. Long-term incubation with β-amyloid peptides impairs endothelium-dependent vasodilatation in isolated rat basilar artery. Pharmacol Res 2010 61 : 157 161
55. Rubanyi GM, Vanhoutte PM. Superoxide anions and hyperoxia inactivate endothelium-derived relaxing factor. Am J Physiol 1986 250 : H822 7
56. Elesber AA, Bonetti PO, Woodrum JE, Zhu XY, Lerman LO, Younkin SG, Lerman A. Bosentan preserves endothelial function in mice overexpressing APP. Neurobiol Aging 2006 27 : 446 450
57. Corder R, Khan N, Barker S. Studies of endothelin-converting enzyme in bovine endothelial cells and vascular smooth-muscle cells: further characterization of the biosynthetic process. J Cardiovasc Pharmacol 1998 31 : S46 8
58. Barker S, Khan NQ, Wood EG, Corder R. Effect of an antisense oligodeoxynucleotide to endothelin-converting enzyme-1c (ECE-1c) on ECE-1c mRNA, ECE-1 protein and endothelin-1 synthesis in bovine pulmonary artery smooth muscle cells. Mol Pharmacol 2001 59 : 163 169
59. Corder R, Khan NQ, Harrison VJ, Wood EG, Lees DM, Barker S. Relationship between soluble intracellular endothelin-converting enzyme and endothelin-1 synthesis: effect of inhibitors of the secretory pathway. J Cardiovasc Pharmacol 2000 36 : S19 21